Manufacturing and Supply Chain
Hands-on expertise to support the management of your manufacturing and supply chain challenges
We bring hands-on expertise and the ability to coordinate manufacturing challenges with regulatory needs
Streamlining your pharmaceutical manufacturing and supply chain
We provide tailored solutions to enhance your manufacturing operations and streamline your supply chain processes. Our team, boasting former plant managers, offers hands-on expertise combined with strategic insight.
PL Consulting’s manufacturing and supply chain support has many facets:
– Manufacturing footprint assessment: Evaluating and optimizing your manufacturing locations to align with business strategy
– Plant productivity and cost management: Identifying efficiencies and reducing waste to boost productivity and control costs
– Due diligence and integration: Expert guidance through mergers and acquisitions, ensuring thorough due diligence and smooth post-merger integration
Our approach integrates manufacturing and supply chain considerations with regulatory and financial implications. This holistic perspective ensures compliance and maximizes your investment return.
PL Consulting provides practical and comprehensive solutions related to manufacturing and supply chain questions
Practical, actionable advice rooted in experience. We are more than simply consultants; we are partners in driving excellence in your pharmaceutical manufacturing and supply chain operations.
Case Study: Strategic and commercial due diligence
We conducted strategic and commercial due diligence on behalf of a large UK FMCG company looking to acquire the space in the life sciences. The focus was on global market drivers and growth, specific country deep-dives (China, US), R&D, manufacturing, and patient journey. A strategic plan for the US, China, and global PMI followed.
Case Study: Manufacturing footprint
Our client, a European multinational pharmaceutical and healthcare company, needed to revisit its manufacturing footprint.
We articulated three manufacturing footprint scenarios in pharma solids, including financial assessment per site (NPV gross margin, cumulated CAPEX, NPV cost of sales, and payback).
We calculated plant and CMO volumes according to the product mix and handed over a modeling tool to assess future scenarios.
Case Study: Manufacturing model transformation
A European midsize pharmaceutical company aimed to transform its manufacturing model.
We defined the manufacturing strategy focusing on technology verticalization, geographical market coverage, and product reallocation. Moreover, we investigated make-or-buy opportunities concerning distribution and logistics functions.